A Phase-1, 6-Month Open-Label, Dose-Ranging Pharmacokinetic Study in Stabilized Patients with Schizophrenia Following Risperidone Implant

Psychopharmacol Bull. 2017 Sep 15;47(4):29-35.
No abstract available

Keywords: dose-ranging; pharmacokinetics; risperidone implant; schizophrenia.

Publication types

  • Retracted Publication